GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com

May
28th

Supplier : US Biomax

Country : USA | Number of Products : 3093 | View all products

About this Supplier: website

35 types of normal human tissue array, 90 cases_96 cores
35 types of normal human tissue array, 90 cases_96 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin
Adamantinoma and hamartoma tissue array, 40 cases_80 cores
Adamantinoma and hamartoma tissue array, 40 cases_80 cores; ihc Anti-Actin confirmed
Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores
Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores; ihc Anti-EMA confirmed
Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases_208 cores
Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases_24 cores
Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases_24 cores; ihc Anti-Actin confirmed
Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores
Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores; ihc Anti-Actin confirmed
Adrenal tumor tissue array, 80 cases_80 cores
Adrenal tumor tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases_80 cores
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
Advanced colon cancer tissue array, with stage and grade info, 80 cases_80 cores
Advanced colon cancer tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores
Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed
Advanced kidney cancer tissue array, with stage and grade info, 80 cases_80 cores
Advanced kidney cancer tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases_80 cores
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
Age grouped female skin tissue array, 12 cases_24 cores, replaced by SK244
Age grouped female skin tissue array, 12 cases_24 cores, replaced by SK244; ihc Anti-Actin confirmed
Age grouped female skin tissue array, 12 cases_24 cores, replacing SK243
Age grouped female skin tissue array, 12 cases_24 cores, replacing SK243
Age grouped female skin tissue array, 12 cases_24 cores, replacing SK243; ihc Anti-Actin confirmed
Antibody cross-reactivity testing tissue array, 33 cases_34 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin
Antibody cross_reactivity testing tissue array, 33 cases_34 cores
Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores
Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores; ihc Anti-Actin confirmed
Astrocytoma and glioblastoma tissue array with unmatched normal adjacent tissues, 48 cases_48 cores; ihc Anti-Actin confirmed
Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores
Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores; ihc Anti-Actin confirmed
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
Bladder cancer high density tissue array, 203 cases_208 cores
Bladder cancer high density tissue array, 203 cases_208 cores; ihc Anti-Actin confirmed
Bladder cancer mid-density tissue array, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Bladder cancer mid_density tissue array, 75 cases_150 cores
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T122; ihc Anti-Actin confirmed
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores; ihc Anti-Actin confirmed
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by T124; ihc Anti-Actin confirmed
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed
Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012
Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012; ihc Anti-Actin confirmed
Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data
Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data; ihc Anti-Actin confirmed
Bladder cancer tissue array with self-matching normal adjacent tissues, 10 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed
Bladder cancer tissue array with self_matching normal adjacent tissues, 10 cases_24 cores
Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data
Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data; ihc Anti-Actin confirmed
Bladder cancer tissue array, 12 cases_24 cores
Bladder cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin
Bladder cancer tissue array, 33 cases_66 cores
Bladder cancer tissue array, 33 cases_66 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin
Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores
Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases_63 cores, replacing BC12011; ihc Anti-Actin confirmed
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BL801
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806; ihc Anti-Cytokeratin (CK) confirmed
Bladder cancer tissue array, with matched adjacent normal tissue (NAT), including TNM and pathology grade, 80 cases_80 cores, replacing BL801; ihc Anti-Actin confirmed
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores; ihc Anti-Actin confirmed
Bladder carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802; ihc Anti-PCNA confirmed
Bladder carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores; ihc Anti-Actin confirmed
Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores
Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing MC809; ihc Anti-Actin confirmed
Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases_80 cores
Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores
Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases_24 cores
Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases_24 cores; ihc Anti-Vimentin (Vim) confirmed
Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases_80 cores
Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases_48 cores with TNM data
Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases_48 cores with TNM data; ihc Anti-Actin confirmed
Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases_24 cores
Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases_24 cores; ihc Anti-Actin confirmed
Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases_24 cores
Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases_24 cores; ihc Anti-Actin confirmed
Bone disease spectrum (bone tumor progression) tissue array, 104 cases_208 cores
Bone disease spectrum (bone tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
Bone giant cell tumor tissue array, 30 cases_60 cores
Bone giant cell tumor tissue array, 30 cases_60 cores; ihc Anti-Vimtin confirmed
Bone marrow tissue array, 12 cases_24 cores
Bone marrow tissue array, 12 cases_24 cores; ihc Anti-Actin confirmed
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482; ihc Anti-Actin confirmed
Bone marrow tumor and normal tissue array, including TNM, 6 cases_24 cores
Bone marrow tumor and normal tissue array, including TNM, 6 cases_24 cores; ihc Anti-Actin confirmed
Brain astrocytoma and meningioma tissue array, 120 cases_120 cores
Brain astrocytoma and meningioma tissue array, 120 cases_120 cores
Brain astrocytoma and meningioma tissue array, 120 cases_120 cores; ihc Anti-Actin confirmed
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T173; ihc Anti-Actin confirmed
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by T175; ihc Anti-Actin confirmed
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replaced by T173a; ihc Anti-Actin confirmed
Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases_80 cores
Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases_80 cores; ihc Anti-Actin confirmed
Brain glioblastoma and normal tissue array, 40 cases_80 cores, replacing GL805
Brain glioblastoma multiforme(GBM) tissue array, 40 cases_80 cores, replaced by GL806a; ihc Anti-Actin confirmed
Brain glioblastoma multiforme(GBM) tissue array, 40 cases_80 cores, replacing GL806; ihc Anti-Actin confirmed
Brain glioblastoma tissue array, 21 cases_63 cores, replaced by GL811
Brain glioblastoma tissue array, 21 cases_63 cores, replaced by GL811; ihc Anti-GFAP confirmed
Brain glioblastoma tissue array, 33 cases_63 cores, replaced by GL805
Brain glioblastoma tissue array, 33 cases_63 cores, replaced by GL805; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed
Brain glioblastoma tissue array, including pathology grade, 40 cases_80 cores, replacing BS17016; ihc Anti-Actin confirmed
Brain gliocytoma tissue array, 63 cases_63 cores
Brain gliocytoma tissue array, 63 cases_63 cores; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed
Brain glioma (astrocytoma) tissue array, 24 cases_72 cores
Brain glioma (astrocytoma) tissue array, 24 cases_72 cores; ihc Anti-Actin confirmed
Brain glioma and normal tissue array, including pathology grade, 40 cases_80 cores
Brain glioma and normal tissue array, including pathology grade, 40 cases_80 cores; ihc Anti-Actin confirmed
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases_24 cores, replaced by T174
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases_24 cores, replaced by T174a; ihc Anti-Actin confirmed
Brain glioma tissue array, 33 cases_63 cores
Brain glioma tissue array, 33 cases_63 cores, replaced by BS17016a; ihc Anti-GFAP confirmed
Brain glioma tissue array, 63 cases_63 cores, replaced by GL803
Brain glioma tissue array, 63 cases_63 cores, replaced by GL803; ihc Anti-GFAP confirmed
Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases_80 cores
Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases_80 cores; ihc Anti-Glial Fibrillary acid protein antibody confirmed
Brain primary tumor high density (69 cases_208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue
Brain primary tumor high density (69 cases_208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue; ihc Anti-Actin confirmed
Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases_208 cores
Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases_80 cores, replacing GL803; ihc Anti-Actin confirmed
Brain tumor and normal tissue array with grade and TNM data, 40 cases_80 cores
Brain tumor and normal tissue array with grade and TNM data, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
Brain tumor and normal tissue array with pathology grade, 208 cases_208 cores
Brain tumor and normal tissue array with pathology grade, 208 cases_208 cores, replaced by GL2083a; ihc Anti-Cytokeratin (CK) confirmed
Brain tumor and normal tissue array with TNM and grade info, 24 cases_72 cores
Brain tumor and normal tissue array with TNM and grade info, 24 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed
Brain tumor and normal tissue array, 50 cases_100 cores
Brain tumor and normal tissue array, 50 cases_100 cores; ihc Anti-Actin confirmed
Brain tumor and normal tissue array, with pathology grade, 27 cases_81 cores, replacing BS17011
Brain tumor and normal tissue array, with pathology grade, 27 cases_81 cores, replacing BS17011; ihc Anti-Actin confirmed
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases_24 cores, replacing T171
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases_24 cores, replacing T171; ihc Anti-Actin confirmed
Brain tumor tissue array for antibody screening, 25 cases_100 cores
Brain tumor tissue array for antibody screening, 25 cases_100 cores; ihc Anti-Actin confirmed
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases_80 cores, replaced by GL803a; ihc Anti-Glial Fibrillary Acid Prot
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases_80 cores, replacing BS17015
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases_24 cores, replacing GL241; ihc Anti-Actin confirmed
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases_24 cores, replacing T172; ihc Anti-Actin confirmed
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases_24 cores, replacing T171; ihc Anti-Actin confirmed
Brain tumor tissue array, including pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
Brain tumor tissue array, with matched adjacent normal tissue, 80 cases_80 cores
Brain tumor tissue array, with matched adjacent normal tissue, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases_48 cores
Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed
Brain tumor tissue array, with normal tissue, 48 cases_48 cores
Brain tumor tissue array, with normal tissue, 48 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed
Brains of multiple species frozen tissue array, 14 cases_15 cores
Brains of multiple species frozen tissue array, 14 cases_15 cores; ihc Anti-Actin confirmed
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BRN801; ihc Anti-Actin confirmed
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores; ihc Anti-Actin confirmed
Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018
Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018; ihc Anti-Actin confirmed
Breast cancer and adjacent normal tissue array, 6 cases_24 cores, replaced by BR243a
Breast cancer and adjacent normal tissue array, 6 cases_24 cores, replacing BR241; ihc Anti-Actin confirmed
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115; ihc Anti-Actin confirmed
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replacing BR1005; ihc Anti-Actin confirmed
Breast cancer and matched metastatic carcinoma of lymph node, 50 cases_100 cores, no overlaps with BR1001 or BR1004
Breast cancer and matched metastatic carcinoma of lymph node, 50 cases_100 cores, no overlaps with BR1001 or BR1004, replaced by BR1005a; ihc Anti-Actin confirmed
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases_100 cores, replacing BR1004
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replaced by BR10010a; ihc Anti-Actin confi
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replacing BR10010; ihc Anti-Actin confirme
Breast cancer and normal tissue array with stage and grade info, 40 cases_80 cores, replaced by BR8014
Breast cancer and normal tissue array with stage and grade info, 40 cases_80 cores, replaced by BR8014; ihc Anti-Actin confirmed
Breast cancer and normal tissue array, 16 cases_48 cores
Breast cancer and normal tissue array, 16 cases_48 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases_96 cores
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases_96 cores; ihc Anti-Actin confirmed
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing BR2001
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing BR2001; ihc Anti-Actin confirmed
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR8012
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR8012; ihc Anti-Actin confirmed
Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer and normal tissue array, non_overlapping with BRC961, with TNM data, 48 cases_96 cores
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases_72 cores, replacing BS08011
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases_72 cores, replacing BS08011; ihc Anti-Actin confirmed
Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR_ER_PR_Her-2(neu) IHC results, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer array with normal and other non-malignant breast tissues, with AR, ER, PR, Her-2 (neu) IHC results, 48 cases_96 cores, replaced by BR963; ihc Anti-Vimentin_Cytokeratin confirmed
Breast cancer array with normal and other non_malignant breast tissues, non_overlapping with BRC962, with AR_ER_PR_Her_2(neu) IHC results, 48 cases_96 cores
Breast cancer array with normal and other non_malignant breast tissues, with AR, ER, PR, Her_2 (neu) IHC results, 48 cases_96 cores, replaced by BR962
Breast cancer array with normal and other non_malignant breast tissues, with AR, ER, PR, Her_2 (neu) IHC results, 48 cases_96 cores, replacing BR961, BR701
Breast cancer frozen tissue array, with normal tissue, 40 cases_40 cores, Her-2 and ER_PR IHC are supplied when purchase; ihc Anti-Actin confirmed
Breast cancer frozen tissue array, with normal tissue, 40 cases_40 cores, Her-2 and ER_PR IHC are supplied when purchase; ihc Anti-Actin confirmed
Breast cancer high-density tissue array, 196 cases_200 cores, replaced by BR2086; ihc Anti-Proliferating Cell Nuclear Antigen (PCNA) confirmed
Breast cancer high_density tissue array, 196 cases_200 cores, replaced by BR2086
Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer mid-density tissue array, non-overlapping with either BRC1501 or BRC1503, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer mid-density tissue array, non-overlapping with either BRC1502 or BRC1503, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer mid-density tissue array, wiht AR_ER_PR_Her-2_P53_EGFR_Ki67 IHC results, 75 cases_150 cores, replaced by BR1503; ihc Anti-Vimentin_Cytokeratin confirmed
Breast cancer mid_density tissue array, non_overlapping with BRC1501 or BRC1502, 75 cases_150 cores
Breast cancer mid_density tissue array, non_overlapping with either BRC1501 or BRC1503, 75 cases_150 cores
Breast cancer mid_density tissue array, non_overlapping with either BRC1502 or BRC1503, 75 cases_150 cores
Breast cancer mid_density tissue array, wiht AR_ER_PR_Her_2_P53_EGFR_Ki67 IHC results, 75 cases_150 cores, replaced by BR1503
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Breast cancer test tissue array with self-matched or unmatched normal adjacent tissues, 6 cases_24 cores.; ihc Anti-Cytokeratin (CK) confirmed
Breast cancer test tissue array with self_matched or unmatched normal adjacent tissues, 6 cases_24 cores.
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T086a; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T085
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T085; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases_24 cores, replaced by T086a; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases_24 cores, replacing T082
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replaced by T087; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replaced by T087a; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T087; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T088
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T088; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases_24 cores, replaced by T084
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases_24 cores, replaced by T084; ihc Anti-Actin confirmed
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing T084
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing T084, replaced by T086a; ihc Anti-Actin confirmed
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases_72 cores
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases_72 cores; ihc Anti-Actin confirmed
Breast cancer tissue array BLOCK, Her-2 IHC marker; ihc Anti-Cytokeratin (CK) confirmed
Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores
Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases_100 cores
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases_24 cores, replaced by BR245
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases_24 cores, replaced by BR245; ihc Anti-Actin confirmed
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_4 cores, replaced by BR042a
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_4 cores, replaced by BR042a; ihc Anti-Actin confirmed
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_8 cores
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_8 cores; ihc Anti-Actin confirmed
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by BR243d; ihc Anti-Actin confirmed
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243c; ihc Anti-Actin confirmed
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases_100 cores, replaced by BR1004
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases_100 cores, replaced by BR1004; ihc Anti-Cytokeratin (Low MW) confirmed
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replaced by BR952; ihc
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replaced by BR954; ihc
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replacing BR952
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replacing BR953; ihc
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, to be replaced by BR95
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores; ihc Anti-Actin confir
Breast cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with TNM data
Breast cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with TNM data; ihc Anti-Actin confirmed
Breast cancer tissue array with normal tissues from autopsy, 80 cases_80 cores, with grade and stage data
Breast cancer tissue array with normal tissues from autopsy, 80 cases_80 cores, with grade and stage data; ihc Anti-Actin confirmed
Breast cancer tissue array with self-matching adjacent tissue and normal tissue, 24 cases_72 cores, no overlaps with other BR TMAs; ihc Anti-Cytokeratin (CK) confirmed
Breast cancer tissue array with self_matching adjacent tissue and normal tissue, 24 cases_72 cores, no overlaps with other BR TMAs
Breast cancer tissue array, 102 cases_102 cores
Breast cancer tissue array, 102 cases_102 cores; ihc H&E, IHC anti-Cytokeratin
Breast cancer tissue array, 64 cases_66 cores, with TNM data
Breast cancer tissue array, 70 cases_70 cores, with TNM data plus ER, PR and Her-2 (C-erbB-2, neu<_em>) IHC results, replaced by BR962; ihc Anti-Actin confirmed
Breast cancer tissue array, 70 cases_70 cores, with TNM data plus ER, PR and Her_2 (C_erbB_2, neu<_em>) IHC results, replaced by BR962
Breast cancer tissue array, including TNM and pathology grade, 216 cases_216 cores
Breast cancer tissue array, including TNM and pathology grade, 216 cases_216 cores; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM and pathology grade, 4 cases_4 cores
Breast cancer tissue array, including TNM and pathology grade, 4 cases_4 cores; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM and pathology grade, 48 cases_48 cores
Breast cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM and pathology grade, 75 cases_150 cores, replaced by BR1503a; ihc Anti-Cytokeratin (CK) confirmed
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her_2, ER, PR, P53 and Ki_67, 75 cases_150 cores, replacing BR1502
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246a
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246a; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR804; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases_150 cores, replacing BR1503; ihc Anti-
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BR803; ihc Anti-Actin confirmed
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases_150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BC08014
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BC08014; ihc Anti-Actin confirmed
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120; ihc Anti-Actin confirmed
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases_80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases_80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b; ihc Anti-Cytokeratin (High MW) con
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases_208 cores, replacing BR2085a
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases_208 cores, replacing BR2085a; ihc Anti-Actin confirmed
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores, replacing T085
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores, replacing T085; ihc Anti-Actin confirmed
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_sllide
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_sllide; ihc Anti-Actin confirmed
Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases_45 cores, with ER, PR and P53 IHC results
Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases_45 cores, with ER, PR and P53 IHC results; ihc Anti-Cytokeratin (CK) confirmed
Breast cancer, adjacent and adjacent normal tissue array, 66 cases_72 cores
Breast cancer, adjacent and adjacent normal tissue array, 66 cases_72 cores; ihc Anti-Actin confirmed
Breast cancer, adjacent and adjacent normal tissue array, 68 cases_72 cores
Breast cancer, adjacent and adjacent normal tissue array, 68 cases_72 cores; ihc Anti-Actin confirmed
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases_100 cores, replacing BC08212
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases_100 cores, replacing BC08212; ihc Anti-Actin confirmed
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021; ihc Anti-ER confirmed
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed
Breast carcinoma (multi-tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728; ihc Anti-PCNA confirmed
Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014; ihc Anti-ER confirmed
Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803; ihc Anti-Cytokeratin (Low-MW) confirmed
Breast carcinoma (multi-tissue combined panel) tissue array, 79 cases_80 cores, replaced by BR803a; ihc Anti-Cytokeratin (Low-MW) confirmed
Breast carcinoma (multi_tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728
Breast carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014
Breast carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803
Breast carcinoma (multi_tissue combined panel) tissue array, 79 cases_80 cores, replacing BC08016
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246; ihc Anti-Actin confirmed
Breast carcinoma tissue array, with stage and grade info, 24 cases_72 cores, replacing BC08015
Breast carcinoma tissue array, with stage and grade info, 24 cases_72 cores, replacing BC08015; ihc Anti-Actin confirmed
Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores
Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores; ihc Anti-Actin confirmed
Breast disease spectrum tissue array - progression array, 48 cases_48 cores; ihc Anti-Actin confirmed
Breast disease spectrum tissue array _ progression array, 48 cases_48 cores
Breast disease spectrum tissue array, 66 cases_72 cores, including normal, precancerous and cancer in different stages
Breast disease spectrum tissue array, 66 cases_72 cores, including normal, precancerous and cancer in different stages; ihc Anti-Cytokeratin (CK) confirmed
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her-2, Ki67, CK14 and p53), 48 cases_96 cores, replaced by BR963a; ihc Anti-Actin conf
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her_2, Ki67, CK14 and p53), 48 cases_96 cores, replacing BR962
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores, replacing BR963; ihc Anti-Actin confirmed
Breast disease tissue array, 18 cases_18 cores
Breast disease tissue array, 18 cases_18 cores; ihc H&E, IHC anti-Cytokeratin
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases_80 cores
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases_80 cores; ihc Anti-Actin confirmed
Breast fibroma and sclerosing adenosis tissue microarray, 30 cases_60 cores
Breast fibroma and sclerosing adenosis tissue microarray, 30 cases_60 cores; ihc Anti-Smooth Muscle Actin (SMA) confirmed
Breast hyperplasia and normal tissue array, 10 cases_30 cores
Breast hyperplasia and normal tissue array, 10 cases_30 cores; ihc Anti-Actin confirmed
Breast hyperplasia tissue array, 80 cases_80 cores
Breast hyperplasia tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases_48 cores
Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases_48 cores; ihc Anti-actin confirmed Certified pathologist code Certified pathologist code
Breast infiltrating ductal carcinoma tissue array, 22 cases_63 cores, replaced by BR727
Breast infiltrating ductal carcinoma tissue array, 22 cases_63 cores, replaced by BR727 ; ihc Anti-ER confirmed
Breast infiltrating lobular carcinoma tissue array, 80 cases_80 cores
Breast infiltrating lobular carcinoma tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases_80 cores
Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases_80 cores; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma forzen tissue array, 20 cases_40 cores
Breast invasive ductal carcinoma forzen tissue array, 20 cases_40 cores; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases_24 cores, replaced by T086b; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replaced by BR243f; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing BR808, BC08014
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing BR808, BC08014; ihc Anti-Actin confirmed
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802; ihc Anti-Actin confirmed
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases_80 cores
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases_80 cores; ihc Anti-Actin confirmed
Breast normal adjacent tissue (NAT) and cancer tissue array, 80 cases_80 cores, replaced by BRN801a; ihc Anti-Actin confirmed
Breast normal adjacent tissue and cancer tissue array, 80 cases_80 cores, replacing BN08013
Breast pre-cancerous disease and cancer tissue array (100 cases_101 cores), with clinical stage and pathology grade data; ihc Anti-Actin confirmed
Breast pre_cancerous disease and cancer tissue array (100 cases_101 cores), with clinical stage and pathology grade data
Breast tumor and normal tissue array, with TNM data, 25 cases_60 cores
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases_100 cores
Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases_100 cores; ihc Anti-Actin confirmed
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804; ihc Anti-Cytokeratin (High MW) confirmed
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804a; ihc Anti-Cytokeratin (Low-MW) confirmed
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases_80 cores
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases_72 cores
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases_72 cores; ihc Anti-Actin confirmed
Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores
Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores, replaced by BC01071a; ihc Anti-P53 confirmed
Carcinoma with adjacent-tissue combined panel tissue array, 44 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed
Carcinoma with adjacent_tissue combined panel tissue array, 44 cases_48 cores
Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases_48 cores
Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases_48 cores; ihc H&E, IHC anti-CD34
Cardiovascular disease tissue array, non-overlapping with CVD481, 23 cases_23 cores; ihc H&E, IHC anti-CD34
Cardiovascular disease tissue array, non_overlapping with CVD481, 23 cases_23 cores
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases_75 cores, replaced by OS803
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases_75 cores, replaced by OS803; ihc Anti-PCNA confirmed
Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases_208 cores
Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
Cervical cancer and normal tissue array with TNM and grade, 40 cases_80 cores
Cervical cancer and normal tissue array with TNM and grade, 40 cases_80 cores; ihc Anti-Actin confirmed
Cervical cancer and normal tissue array with TNM and grade, 50 cases_50 cores
Cervical cancer and normal tissue array with TNM and grade, 50 cases_50 cores; ihc Anti-Actin confirmed
Cervical cancer and normal tissue array, 54 cases_54 cores
Cervical cancer and normal tissue array, 54 cases_54 cores; ihc Anti-Actin confirmed
Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
Cervical cancer and normal tissue array, non-overlapping with CXC962, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
Cervical cancer and normal tissue array, non_overlapping with CXC961, 48 cases_96 cores
Cervical cancer and normal tissue array, non_overlapping with CXC962, 48 cases_96 cores
Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases_208 cores, with grade and stage
Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases_208 cores, with grade and stage; ihc Anti-Actin confirmed
Cervical cancer mid-density tissue array, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Cervical cancer mid_density tissue array, 75 cases_150 cores
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores
Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed
Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data
Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed
Cervical cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with grade and TNM data
Cervical cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with grade and TNM data; ihc Anti-Actin confirmed
Cervical cancer tissue array, 12 cases_24 cores
Cervical cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases_80 cores
Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I-III), 59 cases_60 cores, replaced by CR602; ihc Anti-Cytokeratin (CK)
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I_III), 59 cases_60 cores, replaced by CR602
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases_70 cores
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases_70 cores; ihc Anti-Actin confirmed
Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases_48 cores
Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases_48 cores; ihc H&E, IHC anti-Cytokeratin
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases_48 cores
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed
 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur